Cytogenetic and molecular-genetic aberrations in malignant primary bone tumors;Zytogenetische und molekulargenetische Veranderungen bei bosartigen primaren Knochentumoren

Radiologe

Volumn 38, Issue 6, 1998, Pages 467-471

  Zoubek, A ^a   Kovar, H ^a   Gadner, H ^a  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

Bone tumors; Cytogenetics; Molecular genetics

Indexed keywords

ARTICLE; BONE TUMOR; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; CYTOGENETICS; FIBROSARCOMA; GENE MUTATION; GIANT CELL; HEMANGIOENDOTHELIOSARCOMA; HUMAN; HUMAN TISSUE; MALIGNANT FIBROUS HISTIOCYTOMA; MOLECULAR GENETICS; OSTEOSARCOMA; CHONDROSARCOMA; EWING SARCOMA; GENETICS; MOLECULAR BIOLOGY; PATHOLOGY; REVIEW;

BONE NEOPLASMS; CHONDROSARCOMA; CYTOGENETICS; HUMANS; MOLECULAR BIOLOGY; OSTEOSARCOMA; SARCOMA, EWING'S;

EID: 0032090269     PISSN: 0033832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001170050381     Document Type: Article

References (31)

1. Ambros IM, Ambros PF, Strehl S, Kovar H, Gadner H, Salzer Kuntschik M (1991) MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration. Cancer 67: 1886-1893
2. Armengol G, Tarkkanen M, Virolainen M, Forus A,Valle J, Bohling T, Asko Seljavaara S, Blomqvist C, Elomaa I, Karaharju E, Kivioja AH, Siimes MA, Tukiainen E, Caballin MR, Myklebost O, Knuutila S (1997) Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridization. Br J Cancer 75:1403-1409
3. Boudousquie AC, Lawce HJ, Sherman R, Olson S, Magenis RE, Corless CL (1996) Complex translocation [7;22] identified in an epitheloid hemangioendothelioma. Cancer Genet Cytogenet 92:116-121
4. Bridge JA, Neff JR, DeBoer JM, Synovie J (1992) Cytogenetic findings in 100 cartilaginous neoplasms: bilogical and clinical significance. Cancer Genet Cytogenet 63:126
5. Brody RI, Ueda T, Hamelin A, Jhanwar SC, Bridge JA, Healy JH, Huvos AG, Gerald WL, Ladanyi M (1997) Molecular analysis of the fusion of EWS to an orphan nuclear receptor gene in extraskeletal myxoid chondrosarcoma. Am J Pathol 150:1049-1058
6. Chan HS, Grogan TM, Haddad G, DeBoer G, Ling V (1997) P-glycoprotein expression: critical determinant in the response to osetosarcoma chemotherapy. J Natl Cancer Inst 89:1706-1715
7. Choong PF, Mandahl N, Mertens F, Willen H, Alvegard T, Kreicbergs A, Mitelman F, Rydholm A (1996) 19p+marker chromosome correlates with relapse in malignant fibrous histiocytoma. Genes Chromosomes Cancer 16:88-93
8. Clark J, Benjamin H, Gill S, Sidhar S, Goodwin G, Crew J, Gusterson BA, Shipley J, Cooper CS (1996) Fusion of the EWS gene to CHN, a member of the steroid/thyreoid receptor superfamily, in a human myxoid chondrosarcoma. Oncogene 12:229-235
9. De Alava E, Kawai A, Healey JH, Fligman I, Meyers P, Huvos AG, Gerald WL, Jhanwar SC, Argani P, Antonescu CR, Pardo-Mindan FJ, Ginsberg J, Womer R, Lawlor ER, Wunder J, Andrulis I, Sorensen PHB, Barr FG, Ladanyi M (1998) EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewings sarcoma. J Clin Oncol (in press)
10. Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, Kovar H, Joubert I, De Jong P, Rouleau G et al (1992) Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359:162-165
11. Douglass EC, Rowe ST, Valentine M, Parham D, Meyer WH, Thompson EI (1990) A second nonrandom translocation, der(16)t(1;16)(q21;q13), in Ewing sarcoma and peripheral neuroectodermal tumor. Cytogenet Cell Genet 53:87-90
12. Feugeas O, Guriec N, Babin-Boilletot A, Marcellinl, Simon P, Babin S, Thyss A, Hofman P, Terrier P, Kalifa C, Brunat-Mentigny, Patricot L, Oberling F (1996) Loss of heterozygosity of the Rb gene is a poor prognostic factor in patients with osteosarcoma. J Clin Oncol 14:467-472
13. Hattinger CM, Rumpler S, Ambros IM, Strehl S, Lion T, Zoubek A, Gadner H, Ambros PF (1996) Demonstration of the translocation der(16)t(1;16)(q12;q11.2) in interphase nuclei of Ewing tumors. Genes Chromosomes Cancer 17:141-150
14. Hecht JT, Hogue D, Strong LC, Hansen MF, Blanton SH, Wagner M (1995) Hereditary multiple exostosis and chondrosarcoma: linkage to chromosome 11 and loss of heterozygosity for EXT-linked markers on chromosome 11 and 8. Am J Hum Genet 56:1125-1131
15. Jeon IS, Davis JN, Braun BS, Sublett JE, Roussel MF, Denny CT, Shapiro DN (1995) Avariant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene 10:1229-1234
16. Knezevich SR, McFadden DE, Jao W, Lim JF, Sorensen PHB (1998) A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet 18:184-187
17. Kovar H, Jug G, Aryee DNT, Zoubek A, Ambros P, Gruber B, Windhager R, Gadner H (1997) Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors. Oncogene 15
18. Larramendy ML, Tarkkanen M, Blomquist C, Virolainen M, Wiklund T, Asko-Seljavaara S, Elomaa I, Knuutila S (1997) Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker. Am J Pathol 151:1153-1161
19. Lopez-Gines C, Carda-Batalla C, Lopez-Terrada L, Llombart-Bosch A (1996) Presence of double minutes and monosomy 17p in xenografted human osteosarcomas. Cancer Genet Cytogenet 90:57-62
20. Miller CW, Aslo A, Won A, Tan M, Lampkin B, Koeffler HP (1996) Alterations of the p53, Rb, and MDM2 genes in osteosarcoma. J Cancer Res Clin Oncol 122:559-565
21. Miller CW, Aslo A, Campbell MJ, Kawamata N, Lampkin BC, Koeffler HP (1996) Alterations of the p15, p16, and the p18 genes in osteosarcoma. Cancer Genet Cytogenet 86:136-142
22. Nawa G, Ueda T, Mori S, Yoshikawa H, Fukuda H, Ishiguro S, Funai H, Uchida A (1996) Prognostic significance of Ki67 (MIB1) proliferation index and p53 over-expression in chondrosarcomas. Int J Cancer 69:86-91
23. Peter M, Couturier J, Pacquement H, Michon J, Thomas G, Magdelenat H, Delattre O (1997) A new member of the ETS family fused to EWS in Ewing tumors. Oncogene 14:1159-1164
24. Raskind WH, Conrad EU, Matsushita M (1996) Frequent loss of heterozygosity for markers on chromosome 10q in chondrosarcomas. Genes Chromosomes Cancer 16:138-143
25. Simons A, Janssen IM, Suijkerbuijk RF, Veth RP, Pruszczynski M, Hulsbergen-van de Kaa CA, du Manoir S, Guerts van Kessel A (1997) Isolation of osteosarcoma-associated amplified DAN sequences using representational difference analysis. Genes Chromosomes Cancer 20:196-200
26. Strehl S, Ladenstein R, Wrba F, Salzer-Kuntschik M, Gadner H, Ambros PF (1993) Translocation (12;13) in a case of infantile fibrosarcoma. Cancer Genet Cytogenet 71:94-96
27. Tarkkanen M, Kaipainen A, Karaharju E, Böhling T, Szymanska J, Helio H, Kivioja A, Elomaa I, Knuutila S (1993) Cytogenetic study of 249 consecutive patients examined for a bone tumor. Cancer Genet Cytogenet 68:1-21
28. Toguchida J, Yamaguchi T, Ritchie B, Beauchamp RL, Dayton SH, Herrera GE, Yamamuro T, Kotoura Y, Sasaki MS, Little JB, Weichselbaum RR, lshizaki K,Yandell DW (1992) Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res 52:6194-6199
29. Urano F, Umezawa A, Hong W, Kikuchi H, Hata J (1996) A novel chimera gene between EWS and El A-F, encoding the adenovirus E1A enhancer-binding protein, in extraosseous Ewing's sarcoma. Biochem Biophys Res Commun 219:608-612
30. Walter TA, Weh HJ, Schlag PM, Zornig C, Hossfeld DK (1997) Cytogenetic studies in malignant fibrous histiocytoma. Cancer Genet Cytogenet 94:131-134
31. Zoubek A, Dockhorn Dworniczak B, Delattre O, Christiansen H, Niggli F, Gatterer Menz I, Smith TL, Jurgens H, Gadner H, Kovar H (1996) Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? J Clin Oncol 14:1245-1251